ADAPTING A REGULATORY FRAMEWORK FOR THE EMERGING CANNABIS INDUSTRY

October 1, 2019

The diversity of products that contain cannabis means that a “one-size-fits-all” regulatory framework would be ineffective.

Spotlight

Akrimax Pharmaceuticals, LLC

At Akrimax Pharmaceuticals, we manufacture and market pharmaceutical products with unique and meaningful clinical advantages that improve the lives of patients. Our current commercial portfolio is focused in the areas of cardiovascular medicine, endocrinology and pain management. Akrimax is a sales and marketing company. Our mission is to acquire and commercialize under-promoted, under-utilized pharmaceutical products and those in late stage clinical development.

OTHER WHITEPAPERS
news image

Transforming Patient Journey in Clinical Trials

whitePaper | April 7, 2022

Year after year, the Life Sciences industry expands at a breakneck pace, with pharmaceutical development leading the way.

Read More
news image

Winning with biosimilars Opportunities in global markets

whitePaper | March 14, 2022

Over the past several years, biologics have gained significant traction in the pharmaceutical industry, representing more than $150 billion in global sales in 2013. By 2020 they are predicted to generate $290 billion in revenue and comprise 27 percent of the pharmaceutical market.i

Read More
news image

Effects Of X-Ray Inspection On Pharmaceutical Products

whitePaper | December 12, 2019

X-ray inspection of pharmaceutical products and over-the-counter (OTC) medications are steadily increasing in use as pharmaceutical manufacturers worldwide strive to safeguard their brand reputations, protect consumers' welfare and comply with national and international regulations and legislation.

Read More
news image

Application Notes & Whitepapers 2019

whitePaper | December 19, 2019

Welcome to European Pharmaceutical Review’s Application Notes & Whitepapers Supplement 2019. This year’s topics range from analytical techniques for bioprocess investigation, host cell protein analysis and Raman imaging to advice on outsourcing services for product characterisation.

Read More
news image

Access to medicinal products

whitePaper | January 3, 2022

There are many factors that can prevent a patient from being able to obtain the medicine they need, ranging from selective marketing decisions by companies to products being too expensive or pharmacy stock-outs

Read More
news image

THE PHARMACEUTICAL INDUSTRY AND GLOBAL HEALTH

whitePaper | January 31, 2022

COVID-19 is an infectious disease caused by a newly discovered coronavirus, which was first identified in December 2019.

Read More

Spotlight

Akrimax Pharmaceuticals, LLC

At Akrimax Pharmaceuticals, we manufacture and market pharmaceutical products with unique and meaningful clinical advantages that improve the lives of patients. Our current commercial portfolio is focused in the areas of cardiovascular medicine, endocrinology and pain management. Akrimax is a sales and marketing company. Our mission is to acquire and commercialize under-promoted, under-utilized pharmaceutical products and those in late stage clinical development.

Events